Gut microbiota is one of the largest microbial communities within the human body, yet its origins and early developmental processes remain not fully understood. This study collected samples from 26 mother-infant pairs from the third trimester to 14 days postpartum, using 16S rDNA sequencing and Source Tracker analysis to investigate the dynamic changes and sources of early infant gut microbiota. Results showed that maternal gut microbiota at 32 weeks of gestation was the primary source of meconium microbiota in vaginally delivered infants and continued to influence day-14 gut microbiota, while maternal vaginal microbiota contributed minimally (<1%). Regardless of bacterial presence in breast milk, maternal gut microbiota remained a critical source for day-14 gut microbiota of vaginally delivered infants. Placental microbiota was also an important source of meconium microbiota across different delivery modes. In cesarean-delivered infants, the origins of gut microbiota were more complex, with a higher proportion of “transient bacteria” in meconium, potentially impacting the stable colonization of gut microbiota. However, by day 14, the gut microbiota of cesarean and vaginally delivered infants became similar post-breastfeeding. Correlation network analysis revealed intricate maternal-infant microbial interactions, indicating that maternal microbes may influence the colonization of infant gut microbiota. Shared taxa analysis showed that functional flora might exist in the placenta. Meanwhile, beneficial anaerobes like Bifidobacterium significantly increased in infant day-14 gut microbiota, suggesting their potential role in gut health. Overall, this study provides novel insights into the colonization and developmental patterns of early infant gut microbiota. IMPORTANCE: Gut microbiota exerts a significant impact on an individual's long-term health; however, its origins and colonization processes remain to be fully elucidated. This study revealed that early infant gut microbiota of vaginally delivered infants primarily derived from maternal gut microbiota, which began colonizing the fetus as early as 32 weeks of gestation. In contrast, the contribution of maternal vaginal microbiota to early infant gut microbiota was quite limited. Moreover, placental microbiota also constituted an important source for the fetal gut microbiota. These findings provide novel insights into the developmental mechanisms of infant gut microbiota and highlight the important role of maternal microbes in the early colonization of infant gut microbiota.
28 April 2025 in Journal of Reproductive Immunology
Background: Seminal fluid contains a low‐biomass microbial community that may influence male reproductive health and pregnancy outcomes, but its biological and clinical significance remains uncertain. Objectives: To critically synthesise evidence linking seminal microbiota with sperm quality, reproductive tract inflammation, natural conception, and assisted reproductive technology outcomes, and to evaluate proposed mechanisms and clinical implications. Materials and Methods: This review integrates human observational studies with relevant in vitro, animal, and female reproductive tract evidence, with particular attention to 16S rRNA gene sequencing, low‐biomass contamination, and methodological heterogeneity. Results: Genus‐enriched and compositionally distinct seminal profiles have been reported, but no reproducible community types have been established across populations. Lactobacillus‐enriched profiles are associated with favourable semen parameters in some cohorts, whereas infection‐associated or opportunistic taxa are more often linked to impaired semen characteristics. Proposed pathways include immune activation, oxidative stress, spermmicrobe interactions, and guttestis signalling. Discussion: Evidence remains predominantly observational and heterogeneous, with limited direct mechanistic validation and sparse longitudinal data. Conclusion: Standardised, contamination‐aware studies with independent validation are needed. Current evidence does not support routine seminal microbiome testing or microbiota‐directed interventions in infertility care.
28 June 2026 in American Journal of Reproductive Immunology